The increasing global incidence of chronic diseases demands that novel solutions be developed rapidly and within tight budgets, yet be safe and efficacious enough to withstand stringent regulatory scrutiny. Moreover, the expectation of measurable long term improvement in patient outcomes is driving the need for greater personalisation of therapies. Last but not least, intense competition from traditional and non-traditional players is pushing medical device firms to develop agile product portfolios and processes that can respond to unmet patient needs in a market landscape characterised by constant and rapid scientific, technological, social, and economic change.
The Engineered To Cure industry solution answers these challenges by offering a data-driven & model-based engineering platform that facilitates collaborative design and development of medical devices using best in class apps and processes for 3D design, systems engineering, multiphysics simulations, and virtual human modeling. Using this solution, designers and engineers can rapidly explore the device design space, virtually test promising designs in real world usage scenarios, and validate optimal designs against product requirements and business objectives, while reducing their reliance on expensive and time-consuming physical, animal, and human testing.